Happy Friday, market goers.

Here's a quick look at five stocks that are hitting unusual volume scans right now. Because hey, why not. 

Sanofi

Image placeholder title
  • Thursday's Volume: 5 million
  • Three-Month Average Volume: 1.80 million
  • Volume % Change: 191%

From a technical perspective, Sanofi (SNY) - Get Report spiked notably higher back above its 20-day at $48.66 with large upside volume flows. This stock has been uptrending strong over the past six months, with shares moving higher off its low of $38.55 to its recent high of $50.24 a share. During that move, this stock has been consistently making higher lows and higher highs, which is bullish technical price action.

Traders should now look for long-biased trades in SNY as long as it's trending above its 20-day at $48.66 or above its 50-day at $47.61, and then once it breaks out above some key resistance levels at $50.18 to its 52-week high of $50.24 with volume that hits near or above 1.80 million shares.

Some possible upside targets off that breakout are $52.30 to $53.50, or even $55 to $60 a share.

CRISPER Therapeutics AG

Image placeholder title
  • Thursday's Volume: 209,000
  • Three-Month Average Volume: 83,240
  • Volume % Change: 143%

From a technical perspective, CRISPER Therapeutics AG (CRSP) - Get Report ripped higher and broke out above some key near-term resistance levels at $15.14 to $15.99, and back above its 50-day at $16.14 with above-average volume flows. This high-volume breakout is now quickly pushing this stock within range of triggering another big breakout trade.

Traders should now look for long-biased trades in CRSP as long as it's trending above its previous breakout level at $15.14 or above its 20-day at $14.64, and then once it breaks out above Thursday's intraday high of $16.28 to some more near-term resistance at $17.20 with volume that hits near or above 83,240 shares.

Some possible upside targets off that breakout are $19 to $20, or even $22 a share.

Gilead Sciences Inc.

Image placeholder title
  • Thursday's Volume: 28.96 million
  • Three-Month Average Volume: 7.70 million
  • Volume % Change: 265%

From a technical perspective, Gilead Sciences Inc. (GILD) - Get Report gapped-up sharply higher and broke out above a key downtrend line that dates back to February with monster upside volume. This high-volume breakout is now starting to push this stock within range of triggering another big breakout trade.

Traders should now look for long-biased trades Gilead as long as it's trending above that downtrend line around $68, and then once it clears Thursday's intraday high of $71.44 to some past resistance at $72.16 with volume that hits near or above 7.70 million shares.

Some possible upside targets off that breakout are $75 to $78.25, or even $80 to $85 a share.

Gilead's shares fell 0.1% to $70.38 early Friday afternoon.

More of What's Trending on TheStreet:

Theravance Biopharma

Image placeholder title
  • Thursday's Volume: 436,000
  • Three-Month Average Volume: 220,439
  • Volume % Change: 125%

From a technical perspective, Theravance Biopharma (TBPH) - Get Report ripped sharply higher and broke out above its previous all-time high of $41.48 with monster upside volume flows. Market players should now look for a continuation move to the upside in the short-term if this stock manages to push into new all-time-high territory with strong volume.

Traders should now look for long-biased trades in TBPH as long as it's trending above some near-term support at $40 or above its 50-day at $38.49, and then once it clears or closes above its new all-time high of $42.63 with volume that hits near or above 220,439 shares.

Some possible upside targets off that move are $50 to $55 a share.

Bellicum Pharmaceuticals Inc.

Image placeholder title
  • Thursday's Volume: 2.38 million
  • Three-Month Average Volume: 716,051
  • Volume % Change: 278%

From a technical perspective, Bellicum Pharmaceuticals Inc. (BLCM) - Get Report exploded higher right above its 50-day at $12.34 and into breakout territory above some near-term resistance at $13.61 with monster upside volume flows. This high-volume breakout is now quickly pushing this stock within range of triggering another significant near-term breakout trade.

Traders should now look for long-biased trades in BLCM as long as it's trending above its 50-day at $12.34, and then once it breaks out above some near-term resistance levels at Thursday's intraday high of $14.09 to $14.30 with volume that hits near or above 716,051 shares.

Some possible upside targets off that breakout are its 200-day at $14.93 to $15.55, or even $16.50 to $18 a share.

Visit here for the latest business headlines.

Read More Trending Articles from TheStreet:

  • A Crash in Oil Prices Is Unlikely to Last and This Is a Buying Opportunity, Goldman Sachs Bulls Say
  • Kroger Thinks Amazon Will Make One Massive Change to Whole Foods
  • EpiPen Maker Mylan Was Just Dealt Another Major Blow
  • Here Comes One of the Most Intense Trading Days of the Year: Market Recon
  • Here's Why Friday Will Be One Wild Day on Wall Street

This article is commentary by an independent contributor. At the time of publication, the author held TK positions in the stocks mentioned.